| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Aug 13, 2025 | ELI LILLY & Co | EVP & Pres., Lilly Oncology | Buy | 90.0 | +1,000 | 3.55% | ✗ | $647.4K |
| Feb 1, 2025 | Feb 4, 2025 | ELI LILLY & Co | EVP & Pres., Lilly Oncology | Sell | 17.5 | -1,409 | -6.00% | ✗ | $1.1M |
| Feb 1, 2024 | Feb 2, 2024 | ELI LILLY & Co | EVP & Pres., Loxo@Lilly | Sell | 17.5 | -1,685 | -8.51% | ✗ | $1.1M |
| Feb 16, 2023 | Feb 21, 2023 | ELI LILLY & Co | CEO | Sell | 20.0 | -1,314 | -7.51% | ✗ | $440.2K |
| Feb 16, 2022 | Feb 17, 2022 | ELI LILLY & Co | CEO | Sell | 20.0 | -2,186 | -15.08% | ✗ | $533K |